Clinical Trial Update: SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update reports Restless Legs Syndrome patients switching from pramipexole to ropinirole. The study examines outcomes after the switch.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Restless Legs Syndrome

Drugs mentioned

• Pramipexole (pramipexole)
• Ropinirole (ropinirole)

Snippet

Sponsor: Augusta University | Conditions: Restless Legs Syndrome | Phase 4 | Status: COMPLETED